Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan · Delayed Price · Currency is JPY

261.00

-1.00 (-0.38%)

Oct 23, 2026, 3:30 PM JST

Market Cap	13.13B -12.3%
Revenue (ttm)	6.62B +13.3%
Net Income	688.00M +66.6%
EPS	13.69 +66.4%
Shares Out	50.31M
PE Ratio	19.07
Forward PE	18.13
Dividend	3.50 (1.34%)
Ex-Dividend Date	Dec 29, 2026

Volume	136,500
Open	262.00
Previous Close	262.00
Day's Range	258.00 - 264.00
52-Week Range	246.00 - 317.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incor... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1946

Employees 220

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4574

Full Company Profile

Financial Performance

In 2025, Taiko Pharmaceutical's revenue was 6.40 billion, an increase of 1.67% compared to the previous year's 6.29 billion. Earnings were 923.00 million, an increase of 2.78%.

Financial Statements